Pharmaceutical giant Pfizer has reported a young boy has died due to cardiac arrest after receiving the company’s experimental gene therapy for Duchenne muscular dystrophy.
A Pfizer spokesperson told Reuters in an exclusive email, “A fatal serious adverse event was reported as cardiac arrest for a participant in the Phase 2 DAYLIGHT study.”
Pfizer’s gene therapy trial is currently testing children two to three-year-olds who have Duchenne muscular dystrophy.
According to Johns Hopkins Medicine , Duchenne muscular dystrophy (DMD) “is caused by a genetic problem in producing dystrophin, a protein that protects muscle fibers from breaking down when exposed to enzymes.” BREAKING: A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday. – Stat News pic.twitter.com/qXeeRNApYQ — Insider Paper (@TheInsiderPaper) May 7, 2024 Per Reuters : A young patient died due to cardiac arrest after receiving Pfizer’s gene therapy being […]
Read the Whole Article From the Source: www.thegatewaypundit.com
- Gold SKYROCKETED during Trump’s first term and is poised to do it again. Find out how Genesis Precious Metals can help you secure your retirement with a proper self-directed IRA backed by physical precious metals.